LCLIX
Price
$40.69
Change
+$0.27 (+0.67%)
Updated
Jul 3 closing price
Net Assets
2.35B
RMFCX
Price
$59.46
Change
+$0.39 (+0.66%)
Updated
Jul 3 closing price
Net Assets
108.37B
Interact to see
Advertisement

LCLIX vs RMFCX

Header iconLCLIX vs RMFCX Comparison
Open Charts LCLIX vs RMFCXBanner chart's image
ClearBridge Large Cap Value 1
Price$40.69
Change+$0.27 (+0.67%)
VolumeN/A
Net Assets2.35B
American Funds American Mutual R3
Price$59.46
Change+$0.39 (+0.66%)
VolumeN/A
Net Assets108.37B
LCLIX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LCLIX vs. RMFCX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCLIX is a StrongBuy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 108B vs. LCLIX (2.35B). LCLIX pays higher dividends than RMFCX: LCLIX (1.34) vs RMFCX (1.27). LCLIX was incepted earlier than RMFCX: LCLIX (12 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than LCLIX (0.51). RMFCX is a more actively managed with annual turnover of: 31.00 vs. LCLIX (22.00). LCLIX has a lower initial minimum investment than RMFCX: LCLIX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 11.47 vs. LCLIX (-1.83). RMFCX return over 5 years is better than : 61.83 vs. LCLIX (47.11).
LCLIXRMFCXLCLIX / RMFCX
Total Expense Ratio0.510.9156%
Annual Report Gross Expense Ratio0.510.9156%
Fund Existence12 years23 years-
Gain YTD3.7479.59639%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.35B108B2%
Annual Yield % from dividends1.341.27106%
Returns for 1 year-1.8311.47-16%
Returns for 3 years24.2729.2783%
Returns for 5 years47.1161.8376%
Returns for 10 years58.6479.2174%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX36.410.36
+1.00%
Patient Opportunity C
ESAGX11.980.11
+0.93%
Ashmore Emerging Markets Equity ESG A
EMRGX7.950.07
+0.89%
Emerging Markets Equities Fund M
MSCRX11.020.04
+0.36%
Madison Small Cap R6
TIEWX15.73-0.02
-0.13%
Nuveen International Eq W